FILE:HUM/HUM-8K-20110907083749.txt.gz
EVENTS:	Other Events
TEXT:
ITEM: Other Events
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
 
           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
 
          Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
 
         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
 
         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
 
 
 
 
Item 8.01   Other Events.
 
 
is now reporting that all of its 2012 Medicare Advantage (MA) and Prescription Drug Plan (PDP) offerings filed with the Centers for Medicare and Medicaid Services (CMS) in June 2011 have been approved by CMS and the related contracts have been executed (the CMS Contracts).
In its quarterly report on Form 10-Q for the quarter ended June 30, 2011, Humana Inc. (the Company) disclosed that all material contracts between Humana and CMS relating to the companys Medicare business had been renewed for 2012.  The Company
MA and PDP offerings approved for 2012 include:
 
The marketing process for all 2012 Medicare offerings begins on October 1, 2011, with enrollment beginning October 15, 2011.
 
Each of the CMS Contracts was effective when signed, has a termination date of December 31, 2012 and may be renewed for successive one-year terms subject to the consent of the parties (Humana and CMS) and their agreement on a bid as submitted by Humana or its subsidiaries. Each of the CMS Contracts may be terminated by either party in the event of the failure by the other to substantially carry out its obligations under the CMS Contracts, and by CMS in the event of a violation by Humana of relevant CMS regulations.
 
 
 
 
 
 
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
Dated:           September 7, 2011
 


